Nektar CMO Mary Tagliaferri resigns; Brian Kotzin named interim CMO

NEKTAR THERAPEUTICS

Mary Tagliaferri resigned as SVP and CMO effective Feb 4, 2025, for personal reasons; no disagreement with company.
Brian Kotzin, MD, appointed interim CMO; he previously served as strategic advisor for rezpegaldesleukin program since April 2023.
Kotzin has over 40 years immunology experience; was VP at Amgen and held academic positions; will assist search for permanent CMO.
Kotzin currently serves on boards of Argenx SE, Biora Therapeutics, and Genascence Corporation.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-25-010085
form_type: 8-K
ticker: NKTR
cik: 0000906709
company_name: NEKTAR THERAPEUTICS
filed_at: 2025-02-04T23:59:59+00:00
discovered_at: 2026-05-14T18:03:06.751208+00:00
generated_at: 2026-05-27T03:49:42.672459+00:00
sec_items: ["8.01", "9.01"]
event_type: leadership
sentiment: neutral
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-25-010085
json_url: https://secwatch.observer/filing/0001213900-25-010085.json
markdown_url: https://secwatch.observer/filing/0001213900-25-010085.md
text_url: https://secwatch.observer/filing/0001213900-25-010085.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/906709/000121390025010085/0001213900-25-010085-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/906709/000121390025010085/ea0229922-8k_nektar.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

GRAIL appoints Joshua Ofman as CEO with amended compensation and severance

GRAIL, Inc. June 1, 2026, 4:07 PM ET leadership Items 5.02, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: leadership similar materiality

ARQ

Arq appoints Shimon Steinmetz as CFO, CAO Stacia Hansen resigns

Arq, Inc. May 27, 2026, 4:32 PM ET leadership Items 5.02, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: leadership similar materiality

Select Water Solutions COO Skarke moves to Chief Commercial Officer; no successor named

Select Water Solutions, Inc. June 1, 2026, 5:00 PM ET leadership Items 5.02, 9.01